7.11
-0.04(-0.56%)
Currency In USD
| Previous Close | 7.15 |
| Open | 7.14 |
| Day High | 7.21 |
| Day Low | 6.77 |
| 52-Week High | 16.38 |
| 52-Week Low | 5.28 |
| Volume | 2.28M |
| Average Volume | 2.64M |
| Market Cap | 1.17B |
| PE | -10.94 |
| EPS | -0.65 |
| Moving Average 50 Days | 7.4 |
| Moving Average 200 Days | 8.01 |
| Change | -0.04 |
If you invested $1000 in Wave Life Sciences Ltd. (WVE) 10 years ago, it would be worth $447.45 as of November 18, 2025 at a share price of $7.11. Whereas If you bought $1000 worth of Wave Life Sciences Ltd. (WVE) shares 5 years ago, it would be worth $842.42 as of November 18, 2025 at a share price of $7.11.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Wave Life Sciences to Present Preclinical Data Supporting Therapeutic Potential of WVE-007 for Obesity at ObesityWeek® 2025
GlobeNewswire Inc.
Nov 05, 2025 1:30 AM GMT
Presentation will highlight preclinical data supporting the potential of WVE-007 (INHBE GalNAc-siRNA) as a unique approach for the treatment of obesity designed to drive fat loss while preserving muscle mass with once or twice annual dosing In precli
Wave Life Sciences Third Quarter 2025 Financial Results Scheduled for November 10, 2025
GlobeNewswire Inc.
Nov 04, 2025 1:30 PM GMT
CAMBRIDGE, Mass., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, will host a live webcast and conf
Correcting and Replacing Wave Life Sciences Announced Positive Target Engagement Data from INLIGHT Clinical Trial of WVE-007 for Obesity During Annual Research Day
GlobeNewswire Inc.
Oct 30, 2025 2:50 AM GMT
This press release corrects and replaces the company’s press release issued today, 10/29, at 4:15 p.m. ET in order to correct a typographical error in the first sub-bullet under “WVE-007 (GalNAc-siRNA)” – “Next steps.” Dose-dependent mean reductions